Entive(SZ:300911)2023-04-27 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥228.41 million, a decrease of 7.40% compared to ¥246.66 million in the same period last year[5]. - Net profit attributable to shareholders was ¥40.70 million, down 8.67% from ¥44.56 million year-on-year[5]. - Total revenue for the first quarter was CNY 228,414,228.25, a decrease of 7.8% compared to CNY 246,663,166.49 in the previous period[21]. - The net profit for Q1 2023 was CNY 40.70 million, down from CNY 44.56 million in Q1 2022, reflecting a decrease of approximately 8.56%[22]. - The basic earnings per share for Q1 2023 was CNY 0.3773, compared to CNY 0.4177 in Q1 2022, indicating a decline of about 9.60%[22]. - The company reported a net profit margin of approximately 20.9% for the quarter[21]. - Operating profit for the period was CNY 47,702,063.65, down from CNY 51,081,844.80 in the previous period[21]. Cash Flow and Liquidity - The net cash flow from operating activities increased significantly by 144.32%, reaching ¥32.22 million, compared to a negative cash flow of ¥72.70 million in the previous year[5]. - The cash and cash equivalents at the end of Q1 2023 were CNY 498.03 million, down from CNY 978.88 million at the end of Q1 2022, a decrease of approximately 49.06%[26]. - The company reported cash outflows from investing activities of CNY 560.78 million in Q1 2023, compared to CNY 65.49 million in Q1 2022, indicating a substantial increase in investment expenditures[25]. - The company experienced a negative impact of CNY 33,358.65 from foreign exchange fluctuations on cash and cash equivalents[26]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1.88 billion, reflecting a 2.31% increase from ¥1.84 billion at the end of the previous year[5]. - Total assets increased to CNY 1,878,457,581.27 from CNY 1,836,124,659.09, representing a growth of 2.3%[19]. - Total liabilities amounted to CNY 493,945,469.13, slightly up from CNY 492,504,722.21, an increase of 0.3%[19]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 8,468[12]. - The largest shareholder, Zhejiang Yitian Investment Management Co., Ltd., holds a 43.95% stake in the company[12]. - Major shareholders include Chen Yuehua with 3,266,720 shares (3.04%), Sun Ji with 3,200,000 shares (2.98%), and Sun Weiyong with 3,000,000 shares (2.79%)[13]. - The company has a total of 47,200,000 shares held by Yitian Investment, which are subject to restrictions until December 3, 2023[14]. - The company has 4,000,000 shares held by Yishun Investment, also restricted until December 3, 2023[14]. - The company has 4,000,000 shares held by Yiwan Investment, restricted until December 3, 2023[14]. - The company has 739,350 shares under an equity incentive plan, with 90,000 shares released from restriction during the quarter[14]. - The company’s major shareholders are related, with Sun Weiyong and Chen Yuehua being spouses, and Sun Ji being their son[13]. Research and Development - Research and development expenses rose by 42.13% to ¥12.76 million, indicating increased investment in R&D projects[10]. - Research and development expenses increased to CNY 12,759,607.89, up from CNY 8,977,600.45, indicating a growth of 42.5%[21]. Other Information - The company reported a significant increase in government subsidies, with other income rising by 399.99% to ¥3.07 million[10]. - The weighted average return on equity decreased to 2.98% from 3.66% year-on-year[5]. - The company has not disclosed any other shareholder relationships or concerted actions beyond those mentioned[13]. - The company has not reported any new product developments or market expansion strategies in the provided documents[17]. - The company has not undergone an audit for the Q1 2023 report, as indicated in the documentation[27].